Relafen 750, comprised of naproxen sodium, presents a intriguing case from a biochemical perspective. Its mechanism of action involves inhibiting cyclooxygenase (COX) enzymes, specifically COX-2, which produces a reduction of prostaglandin production . This biochemical route directly affects inflammation and pain perception, highlighting its role a